Arbelo, E. et al. 2023 ESC guidelines for the management of cardiomyopathies. Eur. Heart J. 44, 3503–3626 (2023).

Article  CAS  PubMed  Google Scholar 

Rapezzi, C. et al. Restrictive cardiomyopathy: definition and diagnosis. Eur. Heart J. 43, 4679–4693 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marcus, F. I. et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 121, 1533–1541 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Corrado, D. et al. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report. Int. J. Cardiol. 395, 131447 (2024).

Article  PubMed  Google Scholar 

Zheng, S. L. et al. Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy. Nat. Genet. 56, 2646–2658 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jurgens, S. J. et al. Genome-wide association study reveals mechanisms underlying dilated cardiomyopathy and myocardial resilience. Nat. Genet. 56, 2636–2645 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harper, A. R. et al. Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity. Nat. Genet. 53, 135–142 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hespe, S. et al. Genes associated with hypertrophic cardiomyopathy: a reappraisal by the ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel. J. Am. Coll. Cardiol. 85, 727–740 (2025).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ingles, J. et al. Nonfamilial hypertrophic cardiomyopathy: prevalence, natural history, and clinical implications. Circ. Cardiovasc. Genet. 10, e001620 (2017).

Article  CAS  PubMed  Google Scholar 

Maron, B. A. et al. What causes hypertrophic cardiomyopathy? Am. J. Cardiol. 179, 74–82 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Monda, E. et al. Natural history of hypertrophic cardiomyopathy in Noonan syndrome with multiple lentigines. Circ. Genom. Precis. Med. 16, 350–358 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Limongelli, G. et al. Diagnosis and management of rare cardiomyopathies in adult and paediatric patients. A position paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP). Int. J. Cardiol. 357, 55–71 (2022).

Article  PubMed  Google Scholar 

Bakalakos, A., Monda, E. & Elliott, P. M. The diagnostic and therapeutic implications of phenocopies and mimics of hypertrophic cardiomyopathy. Can. J. Cardiol. 40, 754–765 (2024).

Article  PubMed  Google Scholar 

Jordan, E. et al. Evidence-based assessment of genes in dilated cardiomyopathy. Circulation 144, 7–19 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bourfiss, M. et al. Prevalence and disease expression of pathogenic and likely pathogenic variants associated with inherited cardiomyopathies in the general population. Circ. Genom. Precis. Med. 15, e003704 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Herman, D. S. et al. Truncations of titin causing dilated cardiomyopathy. N. Engl. J. Med. 366, 619–628 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Monda, E. et al. Aetiology and clinical manifestations of patients with non-dilated left ventricular cardiomyopathy. Eur. J. Heart Fail. 26, 2579–2581 (2024).

Article  PubMed  Google Scholar 

Elliott, P. M. et al. Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report. Eur. J. Heart Fail. 21, 955–964 (2019).

Article  PubMed  Google Scholar 

Smith, E. D. et al. Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy. Circulation 141, 1872–1884 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, W. et al. Clinical characteristics and risk stratification of desmoplakin cardiomyopathy. Europace 24, 268–277 (2022).

Article  CAS  PubMed  Google Scholar 

Reichl, K., Kreykes, S. E., Martin, C. M. & Shenoy, C. Desmoplakin variant-associated arrhythmogenic cardiomyopathy presenting as acute myocarditis. Circ. Genom. Precis. Med. 11, e002373 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Corrado, D., Basso, C. & Judge, D. P. Arrhythmogenic cardiomyopathy. Circ. Res. 121, 784–802 (2017).

Article  CAS  PubMed  Google Scholar 

James, C. A., Syrris, P., van Tintelen, J. P. & Calkins, H. The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy. Eur. Heart J. 41, 1393–1400 (2020).

Article  CAS  PubMed  Google Scholar 

Xu, Z. et al. Genotype-phenotype relationship in patients with arrhythmogenic right ventricular cardiomyopathy caused by desmosomal gene mutations: a systematic review and meta-analysis. Sci. Rep. 7, 41387 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Woodhead, J. L. et al. Atomic model of a myosin filament in the relaxed state. Nature 436, 1195–1199 (2005).

Article  CAS  PubMed  Google Scholar 

Rayment, I. et al. Structure of the actin-myosin complex and its implications for muscle contraction. Science 261, 58–65 (1993).

Article  CAS  PubMed  Google Scholar 

Hooijman, P., Stewart, M. A. & Cooke, R. A new state of cardiac myosin with very slow ATP turnover: a potential cardioprotective mechanism in the heart. Biophys. J. 100, 1969–1976 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alamo, L. et al. Conserved intramolecular interactions maintain myosin interacting-heads motifs explaining tarantula muscle super-relaxed state structural basis. J. Mol. Biol. 428, 1142–1164 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nag, S. et al. The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. Nat. Struct. Mol. Biol. 24, 525–533 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashrafian, H. & Watkins, H. Myocardial dysfunction in hypertrophic cardiomyopathy. Circulation 104, E165 (2001).

Article  CAS  PubMed  Google Scholar 

Crilley, J. G. et al. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of